🇺🇸 Individualized dose of rituximab in United States

Individualized dose of rituximab (Individualized dose of rituximab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Individualized dose of rituximab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Individualized dose of rituximab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Individualized dose of rituximab in United States?

Second Affiliated Hospital, School of Medicine, Zhejiang University is the originator. The local marketing authorisation holder may differ — check the official source linked above.